186 related articles for article (PubMed ID: 22157932)
1. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.
Li D; Xiao X; Yang W; Shui R; Tu X; Lu H; Shi D
Mod Pathol; 2012 Apr; 25(4):567-75. PubMed ID: 22157932
[TBL] [Abstract][Full Text] [Related]
2. Basal-like immunophenotype markers and prognosis in early breast cancer.
Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
4. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.
Ding J; Jiang L; Gan Y; Wu W
Int J Clin Exp Pathol; 2015; 8(3):3322-7. PubMed ID: 26045861
[TBL] [Abstract][Full Text] [Related]
5. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
[TBL] [Abstract][Full Text] [Related]
6. Invasive ductal carcinoma of no special type and its corresponding lymph node metastasis: do they have the same immunophenotypic profile?
Fulga V; Rudico L; Balica AR; Cimpean AM; Saptefrati L; Raica M
Pol J Pathol; 2015 Mar; 66(1):30-7. PubMed ID: 26017877
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
[TBL] [Abstract][Full Text] [Related]
10. Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment.
Guo S; Wang Y; Rohr J; Fan C; Li Q; Li X; Wang Z
Breast; 2016 Apr; 26():67-72. PubMed ID: 27017244
[TBL] [Abstract][Full Text] [Related]
11. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in triple-negative breast cancer.
Rakha EA; El-Sayed ME; Green AR; Lee AH; Robertson JF; Ellis IO
Cancer; 2007 Jan; 109(1):25-32. PubMed ID: 17146782
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.
Cakir A; Gonul II; Uluoglu O
Diagn Pathol; 2012 Oct; 7():145. PubMed ID: 23082819
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
[TBL] [Abstract][Full Text] [Related]
15. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
Vasudev P; Onuma K
Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
[TBL] [Abstract][Full Text] [Related]
16. Morphologic spectrum of estrogen receptor-negative breast carcinoma.
Scawn R; Shousha S
Arch Pathol Lab Med; 2002 Mar; 126(3):325-30. PubMed ID: 11860308
[TBL] [Abstract][Full Text] [Related]
17. [Secretory carcinoma of the breast: clinical histopathologic and biological behaviors].
Liu XL; Chen H; Wang Q; Zhang C; Qi DX; Zhang GM; Yang CY
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2434-2437. PubMed ID: 30138990
[No Abstract] [Full Text] [Related]
18. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma.
Hanna MG; Jaffer S; Bleiweiss IJ; Nayak A
Mod Pathol; 2014 Nov; 27(11):1489-98. PubMed ID: 24743214
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features and prognostic significance of basal-like breast cancer].
Liu H; Fan QH; Li X; Liu GZ
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):316-22. PubMed ID: 19575874
[TBL] [Abstract][Full Text] [Related]
20. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
